EP 1196187 A1 20020417 - KERATINOCYTE GROWTH FACTOR-2 FORMULATIONS
Title (en)
KERATINOCYTE GROWTH FACTOR-2 FORMULATIONS
Title (de)
FORMULIERUNGEN üR DEN KERATINOZYTEN-WACHSTUMS-KAKTOR 2
Title (fr)
FORMULATIONS A BASE DE FECTEUR DE CROISSANCE KERATINOCYTAIRE 2
Publication
Application
Priority
- US 0015186 W 20000602
- US 13744899 P 19990602
- US 16091399 P 19991022
Abstract (en)
[origin: WO0072872A1] The invention is directed to liquid and lyophilized forms of Keratinocyte Growth Factor-2 (KGF-2) and derivatives thereof. This invention further relates to the formulations of KGF-2 for therapeutic use, for example, to promote or accelerate wound healing.
IPC 1-7
IPC 8 full level
A61K 9/08 (2006.01); A61K 9/19 (2006.01); A61K 38/00 (2006.01); A61K 38/18 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2006.01); A61K 47/12 (2006.01); A61K 47/14 (2006.01); A61K 47/18 (2006.01); A61K 47/20 (2006.01); A61K 47/22 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 47/34 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61K 47/40 (2006.01); A61K 47/42 (2006.01); A61P 17/02 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP KR)
A61K 38/18 (2013.01 - KR); A61K 38/1825 (2013.01 - EP); A61P 17/02 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0072872 A1 20001207; AU 5593200 A 20001218; CA 2375829 A1 20001207; CN 1359299 A 20020717; EP 1196187 A1 20020417; EP 1196187 A4 20030205; HK 1045816 A1 20021213; JP 2003500456 A 20030107; KR 20020010920 A 20020206; MX PA01012387 A 20020823
DOCDB simple family (application)
US 0015186 W 20000602; AU 5593200 A 20000602; CA 2375829 A 20000602; CN 00809802 A 20000602; EP 00941186 A 20000602; HK 02107430 A 20021011; JP 2000620980 A 20000602; KR 20017015493 A 20011201; MX PA01012387 A 20000602